- Home
- KAVL vs INBS Comparison
KAVL vs INBS Comparison
Compare KAVL & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- KAVL
- INBS
- Stock Information
- Founded
- KAVL 1998
- INBS 2016
- Country
- KAVL United States
- INBS United States
- Employees
- KAVL N/A
- INBS N/A
- Industry
- KAVL Medicinal Chemicals and Botanical Products
- INBS Medical Specialities
- Sector
- KAVL Health Care
- INBS Health Care
- Exchange
- KAVL Nasdaq
- INBS Nasdaq
- Market Cap
- KAVL 7.9M
- INBS 8.7M
- IPO Year
- KAVL N/A
- INBS N/A
- Fundamental
- Price
- KAVL $0.60
- INBS $1.24
- Analyst Decision
- KAVL
- INBS
- Analyst Count
- KAVL 0
- INBS 0
- Target Price
- KAVL N/A
- INBS N/A
- AVG Volume (30 Days)
- KAVL 56.2K
- INBS 113.6K
- Earning Date
- KAVL 06-17-2025
- INBS 05-13-2025
- Dividend Yield
- KAVL N/A
- INBS N/A
- EPS Growth
- KAVL N/A
- INBS N/A
- EPS
- KAVL N/A
- INBS N/A
- Revenue
- KAVL $3,877,695.00
- INBS $2,936,472.00
- Revenue This Year
- KAVL N/A
- INBS $280.88
- Revenue Next Year
- KAVL N/A
- INBS $126.26
- P/E Ratio
- KAVL N/A
- INBS N/A
- Revenue Growth
- KAVL N/A
- INBS 3.87
- 52 Week Low
- KAVL $0.46
- INBS $1.00
- 52 Week High
- KAVL $8.37
- INBS $3.04
- Technical
- Relative Strength Index (RSI)
- KAVL 57.87
- INBS 43.94
- Support Level
- KAVL $0.59
- INBS $1.16
- Resistance Level
- KAVL $0.65
- INBS $1.43
- Average True Range (ATR)
- KAVL 0.04
- INBS 0.10
- MACD
- KAVL 0.02
- INBS 0.02
- Stochastic Oscillator
- KAVL 72.34
- INBS 42.42
About KAVL Kaival Brands Innovations Group Inc.
Kaival Brands Innovations Group Inc is focused on growing and incubating innovative and profitable products. The company is engaged in the sale, marketing and distribution of electronic nicotine delivery system (ENDS) products and related components. Its primary product includes Bidi Stick. The BIDI Stick comes in a variety of flavor options for adult cigarette smokers.
About INBS Intelligent Bio Solutions Inc.
Intelligent Bio Solutions Inc is a life sciences company developing non-invasive, real-time monitoring and diagnostic tests for patients and their primary health practitioners. Its Biosensor Platform is developing and launching diagnostic tests urgently needed to help people living with chronic diseases. It also engages in the advancement of portable drug abuse testing through the analysis of fingerprint sweat. The test is non-invasive, hygienic, and fast, and screens for recent use of opioids, cocaine, methamphetamines, benzodiazepines, and marijuana. The company business through two operating segments include Commercially available Intelligent Fingerprinting Products (IFPG or IFPG segment) and, Development Stage Biosensor Platform Technology (BPT segment).